The loss of regulatory control by p53 leads to increased expression of glycolytic enzymes, including glucose transporter 1 (GLUT-1), HK2, pyruvate kinase M2 (PKM2) and lactate dehydrogenase A (LDHA), thereby fueling tumor growth [47]. Here, SLC2A1 is linked to neoplasm.